Proxy Votes Now

Home › Funds › Hillman Value Fund

Hillman Value Fund (HCMAX) proxy voting record 2025-2026

Fund family: ALPS Series Trust · Filed by ALPS Series Trust (CIK 1558107) · SEC series S000070920

Ticker: HCMAX (C000225205)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 430 with, 31 against, 0 abstentions (not counted as with management); 6 items carried no recommendation. Shareholder proposals: 4 FOR, 27 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other ALPS Series Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 89.4% of this fund’s 461 such votes could be given a sector; the other 49 (10.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care9955.1%
Consumer Staples8533.5%
Consumer Discretionary6769.0%
Industrials6058.3%
Technology47714.9%
Finance2900.0%
Telecommunications25520.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3269
Audit-related400
Say-on-Pay351
Corporate Governance3316
Compensation150
Capital Structure90
Extraordinary Transactions30
Environment or Climate22
Human Rights or Human Capital/workforce22
Other Social Issues11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
FISERV, INC.May 21, 2026$24M41
COMCAST CORPORATIONJune 10, 2026$23M41
DUPONT DE NEMOURS, INC.May 21, 2026$8M140
WEST PHARMACEUTICAL SERVICES, INC.May 4, 2026$4M141
THE ESTEE LAUDER COMPANIES INC.November 13, 2025$3M100
UNITEDHEALTH GROUP INCORPORATEDJune 1, 2026$3M121
BRISTOL-MYERS SQUIBB COMPANYMay 5, 2026$3M151
INTERNATIONAL FLAVORS & FRAGRANCES INC.April 29, 2026$3M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 21, 2026FISERV, INC.Shareholder proposal requesting an independent board chair policy. Shareholder proposalAgainstFor
June 10, 2026COMCAST CORPORATIONAdopt policy to have an independent chair Shareholder proposalAgainstFor
May 4, 2026WEST PHARMACEUTICAL SERVICES, INC.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalAgainstFor
June 1, 2026UNITEDHEALTH GROUP INCORPORATEDIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 5, 2026BRISTOL-MYERS SQUIBB COMPANYShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor
May 14, 2026CVS HEALTH CORPORATIONStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
December 5, 2025MICROSOFT CORPORATIONEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025MICROSOFT CORPORATIONReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
April 23, 2026PFIZER INC.Adopt an Independent Chair Policy Shareholder proposalAgainstFor
May 21, 2026VERIZON COMMUNICATIONSBoard oversight of material issues related to climate change Shareholder proposalAgainstFor
May 21, 2026VERIZON COMMUNICATIONSIndependent board chair Shareholder proposalAgainstFor
May 22, 2026ZIMMER BIOMET HOLDINGS, INC.Shareholder Proposal on Independent Board Chairman. Shareholder proposalAgainstFor

Search this fund’s votes by company

467 ballot items at 36 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Hillman Value Fund (HCMAX) voted at 36 shareholder meetings of 34 companies, on 467 ballot items in all. Where management made a recommendation, the fund followed it on 93.3% of the items and voted against it 31 times. Its most frequent area of disagreement was corporate governance (16 of its votes against management). It voted on 31 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.